BioCentury
ARTICLE | Strategy

Bayer's genomic deal flotilla

January 29, 2001 8:00 AM UTC

Strategy PartnerDateAreaDeal valueGoalMyriad (MYGN)Sep-95Genome targets$137MGenes determining predisposition to obesityMyriad (MYGN)Nov-97Genome targets$54M Targets for dementia, osteoporosis, depres...